These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35088351)

  • 1. Transcriptomic analysis of functional diversity of human umbilical cord blood hematopoietic stem/progenitor cells in erythroid differentiation.
    Soboleva S; Åkerstrand H; Miharada K
    Int J Hematol; 2022 Apr; 115(4):481-488. PubMed ID: 35088351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preeclampsia is Associated with Sex-Specific Transcriptional and Proteomic Changes in Fetal Erythroid Cells.
    Masoumi Z; Maes GE; Herten K; Cortés-Calabuig Á; Alattar AG; Hanson E; Erlandsson L; Mezey E; Magnusson M; Vermeesch JR; Familari M; Hansson SR
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro.
    Nii T; Konno K; Matsumoto M; Bhukhai K; Borwornpinyo S; Sakai K; Hongeng S; Sugiyama D
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transcription factor networks involved in umbilical cord blood CD34+ stem cells-derived erythropoiesis.
    Li B; Ding L; Yang C; Kang B; Liu L; Story MD; Pace BS
    PLoS One; 2014; 9(9):e107133. PubMed ID: 25211130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification.
    Raynaud CM; Butler JM; Halabi NM; Ahmad FS; Ahmed B; Rafii S; Rafii A
    Stem Cell Res; 2013 Nov; 11(3):1074-90. PubMed ID: 23978474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.
    Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E
    PLoS One; 2015; 10(3):e0119086. PubMed ID: 25807521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex Vivo Expansion of CD34
    Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
    Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MEK/ERK signalling pathway promotes erythroid differentiation and reduces HSCs engraftment in ex vivo expanded haematopoietic stem cells.
    Zarrabi M; Afzal E; Asghari MH; Mohammad M; Es HA; Ebrahimi M
    J Cell Mol Med; 2018 Mar; 22(3):1464-1474. PubMed ID: 28994199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative Effect of Erythropoietin and TGF-β Inhibition on Erythroid Development in Human Pluripotent Stem Cells.
    Xie Y; Bai H; Liu Y; Hoyle DL; Cheng T; Wang ZZ
    J Cell Biochem; 2015 Dec; 116(12):2735-43. PubMed ID: 26012423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of AKT activity in human CD34
    Chen S; Gao R; Kobayashi M; Yu H; Yao C; Kapur R; Yoder MC; Liu Y
    Exp Hematol; 2017 Jan; 45():74-84. PubMed ID: 27645691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Erythroid Differentiation and Lentiviral Knockdown in Human CD34+ Cells from Umbilical Cord Blood.
    Kovilakath A; Mohamad S; Hermes F; Wang SZ; Ginder GD; Lloyd JA
    Methods Mol Biol; 2018; 1698():259-274. PubMed ID: 29076096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
    Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
    Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.
    Watt SM; Bühring HJ; Rappold I; Chan JY; Lee-Prudhoe J; Jones T; Zannettino AC; Simmons PJ; Doyonnas R; Sheer D; Butler LH
    Blood; 1998 Aug; 92(3):849-66. PubMed ID: 9680353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells.
    De Smedt M; Leclercq G; Vandekerckhove B; Kerre T; Taghon T; Plum J
    Haematologica; 2011 May; 96(5):646-54. PubMed ID: 21330325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation.
    Wang JF; Wang LJ; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
    Haematologica; 2004 Jul; 89(7):837-44. PubMed ID: 15257936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.
    Andrade PZ; da Silva CL; dos Santos F; Almeida-Porada G; Cabral JM
    J Cell Biochem; 2011 Jul; 112(7):1822-31. PubMed ID: 21400571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.